R. Sztrolovics et al., Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism, BIOCHEM J, 339, 1999, pp. 571-577
A bovine nasal-cartilage culture system has been utilized to analyse the ca
tabolic events occurring in response to interleukin-1 beta Over a 14-day pe
riod. An early event following the start of interleukin-l treatment was the
release of glycosaminoglycan into the culture medium. This release was acc
ompanied by the appearance in the tissue, and shortly thereafter also in th
e culture media, of a globular domain (G1)-containing aggrecan degradation
product generated by the action of aggrecanase. Link protein was also relea
sed from the cartilage with a similar timeframe to that of the G1 fragment,
although there was no evidence of its proteolytic degradation. By comparis
on with aggrecan, the small leucine-rich repeat proteoglycans decorin, bigl
ycan and lumican showed a resistance to both proteolytic cleavage and relea
se throughout the culture period. In contrast, fibromodulin exhibited a mar
ked decrease in size after day 4, presumably due to proteolytic modificatio
n, but the major degradation product was retained throughout the culture pe
riod. Also in contrast with the early changes in the components of the prot
eoglycan aggregate, type II collagen did not display signs of extensive deg
radation until much later in the culture period. Collagen degradation produ
cts compatible with collagenase action first appeared in the medium by day
10 and increased thereafter. These data demonstrate that the leucine-rich r
epeat proteoglycans are resistant to proteolytic action during interleukin-
l-stimulated cartilage catabolism, compared with aggrecan. This resistance
and continued interaction with the surface of the collagen fibrils may help
to stabilize the collagen fibrillar network and protect it from extensive
proteolytic attack during the early phases of cartilage degeneration.